The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins
Open accessAbstract
The aryl hydrocarbon receptor (AHR) is a ligand-dependent transcription factor best known for mediating the toxicity of dioxin. Environmental factors are believed to contribute to the increased prevalence of autoimmune diseases, many of which are due to the activity of T(H)17 T cells, a new helper T-cell subset characterized by the production of the cytokine IL-17. Here we show that in the CD4+ T-cell lineage of mice AHR expression is restricted to the T(H)17 cell subset and its ligation results in the production of the T(H)17 cytokine interleukin (IL)-22. AHR is also expressed in human T(H)17 cells. Activation of AHR by a high-affinity ligand during T(H)17 cell development markedly increases the proportion of T(H)17 T cells and their production of cytokines. CD4+ T cells from AHR-deficient mice can develop T(H)17 cell responses, but when confronted with AHR ligand fail to produce IL-22 and do not show enhanced T(H)17 cell development. AHR activation during induction of experimental autoimmune encephalomyelitis causes accelerated onset and increased pathology in wild-type mice, but not AHR-deficient mice. AHR ligands may therefore represent co-factors in the development of autoimmune diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Accordingly, many phenotypes of Ahr mutant models such as altered hepatovascular development and impaired immune function, do not appear to be directly related to TCDD toxicity or adaptive metabolism (Quintana et al., 2008; Stockinger et al., 2014; Veldhoen et al., 2008; Walisser et al., 2005)”
From Rodent Genetic Models of Ah Receptor Signaling (2021) · cites this paper as Veldhoen et al., 2008
In the citing paper
“it was demonstrated that expression of IL-22 requires the AhR (Martin et al., 2009; Veldhoen et al., 2008).”
From Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System (2017) · cites this paper as Veldhoen et al., 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Liang, S. C., Tan, X.-Y., Luxenberg, D. P., Karim, R., Dunussi-Joannopoulos, K., Collins, M., & Fouser, L. A. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20061308 · Cited by 2,330
Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis
Zheng, Y., Danilenko, D. M., Valdez, P. A., Kasman, I. M., Eastham‐Anderson, J., Wu, J., & Ouyang, W. (2006) · Nature · doi:10.1038/nature05505 · Cited by 1,888
Surface phenotype and antigenic specificity of human interleukin 17–producing T helper memory cells
Acosta-Rodriguez, E. V., Rivino, L., Geginat, J., Jarrossay, D., Gattorno, M., Lanzavecchia, A., Sallusto, F., & Napolitani, G. (2007) · Nature Immunology · doi:10.1038/ni1467 · Cited by 1,828
Kebir, H., Kreymborg, K., Ifergan, I., Dodelet-Devillers, A., Cayrol, R., Bernard, M., Giuliani, F., Arbour, N., Becher, B., & Prat, A. (2007) · Nature Medicine · doi:10.1038/nm1651 · Cited by 1,759
Immune System Impairment and Hepatic Fibrosis in Mice Lacking the Dioxin-Binding Ah Receptor
Fernandez-Salguero, P., Pineau, T., Hilbert, D. M., McPhail, T., Lee, S. S. T., Kimura, S., Nebert, D. W., Rudikoff, S., Ward, J. M., & Gonzalez, F. J. (1995) · Science · doi:10.1126/science.7732381 · Cited by 1,075
Hirota, K., Yoshitomi, H., Hashimoto, M., Maeda, S., Teradaira, S., Sugimoto, N., Yamaguchi, T., Nomura, T., Ito, H., Nakamura, T., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20071397 · Cited by 937
Self-citationSchmidt, J. V., Su, G. H., Reddy, J. K., Simon, M. C., & Bradfield, C. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.13.6731 · Cited by 902
AH RECEPTOR SIGNALING PATHWAYS
Schmidt, J. V., & Bradfield, C. A. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.55 · Cited by 899
Flagged first, then by citations
Cited by
Sorted by citations
Items 701–800 of 1,001
Th17 lineage commitment and HIV-1 pathogenesis
Ancuța, P., Monteiro, P., & Sékaly, R. (2010) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e3283364733 · Cited by 50
The role of STAT3 and AhR in the differentiation of CD4+ T cells into Th17 and Treg cells
Liu, X., Hu, H., Fan, H., Zuo, D., Shou, Z., Liao, Y., Nan, Z., & Tang, Q. (2017) · Medicine · doi:10.1097/md.0000000000006615 · Cited by 50
Aryl Hydrocarbon Receptor Activation Suppresses EBF1 and PAX5 and Impairs Human B Lymphopoiesis
Li, J., Bhattacharya, S., Zhou, J., Phadnis-Moghe, A. S., Crawford, R. B., & Kaminski, N. E. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1700289 · Cited by 51
Signaling pathways that regulate Trypanosoma cruzi infection and immune response
Cerbán, F. M., Stempin, C. C., Volpini, X., Silva, E. A. C., Gea, S., & Motrán, C. C. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165707 · Cited by 53
A diet-dependent host metabolite shapes the gut microbiota to protect from autoimmunity
Alexander, M., Upadhyay, V., Rock, R., Ramirez, L., Trepka, K. R., Puchalska, P., Orellana, D. A., Ang, Q. Y., Whitty, C., Turnbaugh, J. A., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114891 · Cited by 48
The role of T helper subsets in autoimmunity and allergy
Veldhoen, M. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.07.009 · Cited by 50
Self-citationWong, L. Y., Hatfield, J. K., & Brown, M. A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.481440 · Cited by 53
Aryl Hydrocarbon Receptor (AhR) Regulates Silica-Induced Inflammation But Not Fibrosis
Beamer, C. A., Seaver, B. P., & Shepherd, D. M. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs024 · Cited by 48
Genes associated with T helper 17 cell differentiation and function
Nalbant, A. (2016) · Frontiers in Bioscience-Elite · doi:10.2741/777 · Cited by 49
The Aryl Hydrocarbon Receptor in Immunity: Tools and Potential
Esser, C. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-3139-2_16 · Cited by 49
Cytochrome P450s in human immune cells regulate IL-22 and c-Kit via an AHR feedback loop
Effner, R., Hiller, J., Eyerich, S., Traidl‐Hoffmann, C., Brockow, K., Triggiani, M., Behrendt, H., Schmidt‐Weber, C. B., & Buters, J. (2017) · Scientific Reports · doi:10.1038/srep44005 · Cited by 50
Schiering, C., Vonk, A., Das, S., Stockinger, B., & Wincent, E. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.02.031 · Cited by 48
Self-citationYamamoto, T., Hiraiwa, T., Tobita, R., Hirano, H., Masuda‐Kuroki, K., Ishii, M., Murakami, M., Terui, T., & Okubo, Y. (2020) · International Journal of Dermatology · doi:10.1111/ijd.14788 · Cited by 48
The cross-talk between opportunistic fungi and the mammalian host via microbiota’s metabolism
Romani, L., Zelante, T., Palmieri, M., Napolioni, V., Picciolini, M., Velardi, A., Aversa, F., & Puccetti, P. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-014-0464-2 · Cited by 47
MAIT Cells in Barrier Tissues: Lessons from Immediate Neighbors
Amini, A., Pang, D., Hackstein, C.-P., & Klenerman, P. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.584521 · Cited by 49
Hwang, J., Newton, E. M., Hsiao, J. L., & Shi, V. Y. (2022) · Experimental Dermatology · doi:10.1111/exd.14541 · Cited by 47
Lu, S., Wang, C., Ma, J., & Wang, Y. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1456030 · Cited by 49
Gut Microbiota, Probiotics and Inflammatory Bowel Disease
Stephani, J., Radulovic, K., & Niess, J. H. (2011) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-011-0122-5 · Cited by 50
Costa, M. M., Saraceni, P. R., Forn‐Cuní, G., Dios, S., Romero, A., Figueras, A. J., & Novoa, B. (2013) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2013.08.021 · Cited by 48
Tong, B., Yuan, X., Dou, Y., Wu, X., Chou, G., Wang, Z., Xia, Y., & Dai, Y. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.03.014 · Cited by 48
A systematic review of gut‐immune‐brain mechanisms in Autism Spectrum Disorder
Azhari, A., Azizan, F., & Esposito, G. (2018) · Developmental Psychobiology · doi:10.1002/dev.21803 · Cited by 52
The role of T helper 17 and regulatory T cells in tumor microenvironment
Najafi, S., & Mirshafiey, A. (2019) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2019.1566925 · Cited by 49
Ectonucleotidases in Intestinal and Hepatic Inflammation
Vuerich, M., Robson, S. C., & Longhi, M. S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00507 · Cited by 48
Guarnieri, T., Abruzzo, P. M., & Bolotta, A. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00493.2019 · Cited by 49
Kiluk, M., Lewkowicz, J., Pawlak, D., & Tankiewicz‐Kwedlo, A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10112484 · Cited by 50
Gfi1 negatively regulates Th17 differentiation by inhibiting ROR t activity
Ichiyama, K., Hashimoto, M., Sekiya, T., Nakagawa, R., Wakabayashi, Y., Sugiyama, Y., Komai, K., Saba, I., Möröy, T., & Yoshimura, A. (2009) · International Immunology · doi:10.1093/intimm/dxp054 · Cited by 48
The Special Relationship in the Development and Function of T Helper 17 and Regulatory T Cells
Lochner, M., Wang, Z., & Sparwasser, T. D. (2015) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2015.07.013 · Cited by 48
Okudaira, N., Iijima, K., Koyama, T., Minemoto, Y., Kano, S., Mimori, A., & Ishizaka, Y. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001252107 · Cited by 50
Exploiting IL-17-producing CD4+ and CD8+ T cells to improve cancer immunotherapy in the clinic
Majchrzak, K., Nelson, M. H., Bailey, S. R., Bowers, J. S., Yu, X., Rubinstein, M. P., Himes, R. A., & Paulos, C. M. (2016) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-016-1797-6 · Cited by 48
Nikamo, P., Cheuk, S., Lysell, J., Enerbäck, C., Bergh, K., Xu, N., Eidsmo, L., & Ståhle, M. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.5 · Cited by 45
The IL-17A/IL-17RA axis in pulmonary defence and immunopathology
Lorè, N. I., Bragonzi, A., & Cigana, C. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.03.009 · Cited by 45
Jaligama, S., Patel, V., Wang, P., Sallam, A., Harding, J. N., Kelley, M. A., Mancuso, S. R., Dugas, T. R., & Cormier, S. A. (2018) · Particle and Fibre Toxicology · doi:10.1186/s12989-018-0255-3 · Cited by 45
Antibiotics and autoimmune and allergy diseases: Causative factor or treatment?
Strzępa, A., Lobo, F. M., Majewska‐Szczepanik, M., & Szczepanik, M. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.10.021 · Cited by 46
Microbe-metabolite-host axis, two-way action in the pathogenesis and treatment of human autoimmunity
Meng, X. L., Zhou, H., Shen, H., Lufumpa, E., Li, X., Guo, B., & Li, B. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2019.03.006 · Cited by 46
Fujita, Y., Yonehara, M., Tetsuhashi, M., Noguchi‐Yachide, T., Hashimoto, Y., & Ishikawa, M. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.12.036 · Cited by 45
O’Connor, R. A., Taams, L. S., & Anderton, S. M. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2009.04040.x · Cited by 46
Shetty, A., Tripathi, S. K., Junttila, S., Buchacher, T., Biradar, R., Bhosale, S. D., Envall, T., Laiho, A., Moulder, R., Rasool, O., et al. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac256 · Cited by 46
Molecular underpinnings of Th17 immune-regulation and their implications in autoimmune diabetes
Kumar, P., & Subramaniyam, G. (2014) · Cytokine · doi:10.1016/j.cyto.2014.10.010 · Cited by 46
Nugent, L. F., Shi, G., Vistica, B. P., Ogbeifun, O., Hinshaw, S. J. H., & Gery, I. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-11479 · Cited by 45
Sasaki, C. Y., Chen, G., Munk, R. B., Eitan, E., Martindale, J. L., Longo, D. L., & Ghosh, P. (2015) · European Journal of Immunology · doi:10.1002/eji.201445422 · Cited by 45
Suppression of Th1 differentiation by tryptophan supplementation in vivo
Lanz, T. V., Becker, S., Mohapatra, S. R., Opitz, C. A., Wick, W., & Platten, M. (2017) · Amino Acids · doi:10.1007/s00726-017-2415-4 · Cited by 45
Expression, Localization, and Activity of the Aryl Hydrocarbon Receptor in the Human Placenta
Wakx, A., Nedder, M., Tomkiewicz, C., Dalmasso, J., Chissey, A., Boland, S., Vibert, F., Degrelle, S. A., Fournier, T., Coumoul, X., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123762 · Cited by 48
Immune Response Activation and Immunomodulation
Tyagi, R. K., & Bisen, P. S. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.73708 · Cited by 44
Sun, L., Ye, Z., Ling, Y., Cai, S., Xu, J., Fan, C., Zhong, Y., Shen, Q., & Li, Y. (2019) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2019.135294 · Cited by 44
Brembilla, N. C., Ramirez, J., Chicheportiche, R., Sorg, O., Saurat, J. ‐., & Chizzolini, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018741 · Cited by 45
Xie, J., Wang, Z., & Wang, W. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02151 · Cited by 43
The influence of AHR on immune and tissue biology
Stockinger, B., Diaz, O. E., & Wincent, E. (2024) · EMBO Molecular Medicine · doi:10.1038/s44321-024-00135-w · Cited by 43
Self-citationBiotoxin sensing in food and environment via microchip
Zhang, Z., Yu, L., Xu, L., Hu, X., Li, P., Zhang, Q., Ding, X., & Feng, X. (2014) · Electrophoresis · doi:10.1002/elps.201300570 · Cited by 43
Targeting the IL17 Pathway for the Prevention of Graft-Versus-Host Disease
van der Waart, A. B., van der Velden, W. J. F. M., Blijlevens, N. M. A., & Dolstra, H. (2014) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2014.02.007 · Cited by 43
Innate lymphoid cells: from border protection to the initiation of inflammatory diseases
Sanos, S. L., & Diefenbach, A. (2013) · Immunology and Cell Biology · doi:10.1038/icb.2013.3 · Cited by 43
Cochez, P. M., Michiels, C., Hendrickx, E., Belle, A. B. V., Lemaire, M. M., Dauguet, N., Warnier, G., de Heusch, M., Togbe, D., Ryffel, B., et al. (2016) · European Journal of Immunology · doi:10.1002/eji.201546070 · Cited by 45
Self-citationO’Driscoll, C. A., & Mezrich, J. D. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02833 · Cited by 47
Kim, H. R., Kim, J. C., Kang, S. Y., Kim, H. O., Park, C. W., & Chung, B. Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083968 · Cited by 43
Cui, X., Ye, Z., Wang, D., Yang, Y., Jiao, C., Ma, J., Tang, N., & Zhang, H. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00780-z · Cited by 45
IL‐22‐producing CD4+ T cells: Middle‐men between the immune system and its environment
Trifari, S., & Spits, H. (2010) · European Journal of Immunology · doi:10.1002/eji.201040848 · Cited by 43
Gene transcription in polar bears (Ursus maritimus) from disparate populations
Bowen, L., Miles, A. K., Waters, S. C., Meyerson, R., Rode, K. D., & Atwood, T. C. (2015) · Polar Biology · doi:10.1007/s00300-015-1705-0 · Cited by 42
Stephens, G. L., Wang, Q., Swerdlow, B., Bhat, G., Kolbeck, R., & Fung, M. S. C. (2013) · European Journal of Immunology · doi:10.1002/eji.201242779 · Cited by 44
Zhou, Q., Lavorgna, A., Bowman, M., Hiscott, J. B., & Harhaj, E. W. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.633065 · Cited by 43
Control of the immune system by oxysterols and cancer development
Traversari, C., & Russo, V. E. A. (2012) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2012.07.003 · Cited by 42
Immunoregulatory molecules are master regulators of inflammation during the immune response
de la Fuente, H., Cibrián, D., & Sánchez‐Madrid, F. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.07.032 · Cited by 43
Zhu, J., Cao, Y., Li, K., Wang, Z., Zuo, P., Xiong, W., Xu, Y., & Xiong, S. (2011) · PubMed · Cited by 42
Liu, C. C., Xia, M., Zhang, Y. J., Jin, P., Zhao, L., Zhang, J., Li, T., Zhou, X. M., Tu, Y. Y., Kong, F., et al. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.03.204 · Cited by 42
Park, J., Lee, J.-M., Lee, E.-J., Hwang, W.-B., & Kim, D.-J. (2018) · Europe PMC (PubMed Central) · doi:10.14348/molcells.2018.2167 · Cited by 42
Kim, W. H., Lillehoj, H. S., & Min, W. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00560 · Cited by 42
Singh, N. P., Nagarkatti, M., & Nagarkatti, P. S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217849 · Cited by 44
Zhang, R.-D., Chen, C., Wang, P., Fang, Y., Jiang, L.-Q., Fang, X., Zhao, Y., Ni, J., Wang, D., & Pan, H. (2023) · Environmental Geochemistry and Health · doi:10.1007/s10653-023-01495-x · Cited by 41
Nuclear receptors in the cross-talk of drug metabolism and inflammation
Gerbal‐Chaloin, S., Iankova, I., Maurel, P., & Daujat‐Chavanieu, M. (2013) · Drug Metabolism Reviews · doi:10.3109/03602532.2012.756011 · Cited by 41
Hu, W., Zhao, J., & Pei, G. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.475624 · Cited by 41
The potential of targeting indoleamine 2,3-dioxygenase for cancer treatment
Gostner, J. M., Becker, K., Überall, F., & Fuchs, D. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.995092 · Cited by 41
Bowen, L., Miles, A. K., Murray, M. J., Haulena, M., TUTTLE, J., Bonn, W. G. V., Adams, L., Bodkin, J. L., Ballachey, B. E., ESTES, J., et al. (2011) · Molecular Ecology Resources · doi:10.1111/j.1755-0998.2011.03060.x · Cited by 42
Shaping the Glioma Immune Microenvironment Through Tryptophan Metabolism
Platten, M., Weller, M., & Wick, W. (2012) · CNS Oncology · doi:10.2217/cns.12.6 · Cited by 41
Association of particulate matter with autoimmune rheumatic diseases among adults in South Korea
Park, J. J., Choi, S., Kim, K., Chang, J., Kim, S. M., Kim, S. R., Lee, G., Son, J. S., Kim, K. H., Lee, E. Y., et al. (2021) · Rheumatology · doi:10.1093/rheumatology/keab127 · Cited by 42
Dorgham, K., Amoura, Z., Parizot, C., Arnaud, L., Francès, C., Pionneau, C., Devilliers, H., Pinto, S., Zoorob, R., Miyara, M., et al. (2015) · European Journal of Immunology · doi:10.1002/eji.201445144 · Cited by 42
The gut–brain connection: triggering of brain autoimmune disease by commensal gut bacteria
Wekerle, H. (2016) · Rheumatology · doi:10.1093/rheumatology/kew353 · Cited by 41
Badawy, A. A. ‐. (2023) · Bioscience Reports · doi:10.1042/bsr20230595 · Cited by 43
Griffith, B. D., & Frankel, T. L. (2024) · Cancers · doi:10.3390/cancers16030472 · Cited by 45
Ishida, M., Mikami, S., Shinojima, T., Kosaka, T., Mizuno, R., Kikuchi, E., Miyajima, A., Okada, Y., & Oya, M. (2014) · International Journal of Cancer · doi:10.1002/ijc.29398 · Cited by 44
Molecular Mechanisms of Differentiation of Murine Pro-Inflammatory γδ T Cell Subsets
Serre, K., & Silva‐Santos, B. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00431 · Cited by 41
Li, J., Doty, A. L., & Glover, S. C. (2016) · Inflammation and Cell Signaling · doi:10.14800/ics.1404 · Cited by 40
Perfluorooctane sulfonate affects intestinal immunity against bacterial infection
Suo, C., Fan, Z., Zhou, L., & Qiu, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-04091-z · Cited by 40
Towards Targeting the Aryl Hydrocarbon Receptor in Cystic Fibrosis
Puccetti, M., Paolicelli, G., Oikonomou, V., LUCA, A. D., Renga, G., Borghi, M., Pariano, M., Stincardini, C., Scaringi, L., Giovagnoli, S., et al. (2018) · Mediators of Inflammation · doi:10.1155/2018/1601486 · Cited by 41
Advances in nanomedicine for the treatment of ankylosing spondylitis
Xi, Y., Jiang, T., Chaurasiya, B., Zhou, Y., Yu, J., Wen, J., Shen, Y., Ye, X., & Webster, T. J. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s216199 · Cited by 40
Jonescheit, H., Oberg, H., Gonnermann, D., Hermes, M., Sulaj, V., Peters, C., Kabelitz, D., & Wesch, D. (2020) · Cells · doi:10.3390/cells9051140 · Cited by 42
Endocrine disrupting chemicals and COVID-19 relationships: A computational systems biology approach
Wu, Q., Coumoul, X., Grandjean, P., Barouki, R., & Audouze, K. (2020) · Environment International · doi:10.1016/j.envint.2020.106232 · Cited by 40
Counter-regulation of T cell effector function by differentially activated p38
Alam, M. S., Gaida, M. M., Ogawa, Y., Kolios, A. G. A., Lasitschka, F., & Ashwell, J. D. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20131917 · Cited by 40
Mezrich, J. D., Nguyen, L. P., Kennedy, G., Nukaya, M., Fechner, J. H., Zhang, X., Xing, Y., & Bradfield, C. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044547 · Cited by 40
Heterogeneity of tissue resident memory T cells
Konjar, Š., Ficht, X., Iannacone, M., & Veldhoen, M. (2022) · Immunology Letters · doi:10.1016/j.imlet.2022.02.009 · Cited by 40
Self-citationA patient-centric modeling framework captures recovery from SARS-CoV-2 infection
Ruffieux, H., Hanson, A., Lodge, S., Lawler, N. G., Whiley, L., Gray, N., Nolan, T. H., Bergamaschi, L., Mescia, F., Turner, L., et al. (2023) · Nature Immunology · doi:10.1038/s41590-022-01380-2 · Cited by 40
Aryl Hydrocarbon Receptor Signalling in the Control of Gut Inflammation
Marafini, I., Monteleone, I., Laudisi, F., & Monteleone, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25084527 · Cited by 41
Prigent, L., Robineau, M., Jouneau, S., Morzadec, C., Louarn, L., Vernhet, L., Fardel, O., & Sparfel, L. (2014) · European Journal of Immunology · doi:10.1002/eji.201343920 · Cited by 45
Wagage, S., Pritchard, G. H., Dawson, L. A., Buza, E. L., Sonnenberg, G. F., & Hunter, C. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128335 · Cited by 40
Pediatric Immune Dysfunction and Health Risks Following Early-Life Immune Insult
Dietert, R. R., & Zelikoff, J. T. (2009) · Current Pediatric Reviews · doi:10.2174/157339609787587591 · Cited by 39
An increased proportion of circulating Th22 and Tc22 cells in psoriasis
Li, L., Ding, Y., Han, S., Zhang, Z., & Liu, X. (2014) · Cellular Immunology · doi:10.1016/j.cellimm.2014.06.007 · Cited by 39
Gorska, M. (2017) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000327 · Cited by 21
β-Lactam hypersensitivity involves expansion of circulating and skin-resident TH22 cells
Sullivan, A. K., Wang, E., Farrell, J., Whitaker, P., Faulkner, L., Peckham, D. G., Park, B. K., & Naisbitt, D. J. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.01.020 · Cited by 39
AHR signaling in the development and function of intestinal immune cells and beyond
Cervantes‐Barragán, L., & Colonna, M. (2018) · Seminars in Immunopathology · doi:10.1007/s00281-018-0694-9 · Cited by 41
Function of Pro-Resolving Lipid Mediator Resolvin E1 in Type 2 Diabetes
Sima, C., Paster, B. J., & Dyke, T. E. V. (2018) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2018026750 · Cited by 41
New and Emerging Therapies for Pediatric Atopic Dermatitis
Nguyen, H. L., Anderson, K., & Tollefson, M. M. (2019) · Pediatric Drugs · doi:10.1007/s40272-019-00342-w · Cited by 41
Aryl Hydrocarbon Receptor and Dioxin-Related Health Hazards—Lessons from Yusho
Furue, M., Ishii, Y., Tsukimori, K., & Tsuji, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020708 · Cited by 39
Fine-tuning of T cell responses during infection
Dorhoi, A., & Kaufmann, S. H. E. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.07.004 · Cited by 39
Metadata
- Authors
- Veldhoen, M., Hirota, K., Westendorf, A. M., Buer, J., Dumoutier, L., Renauld, J.-C., & Stockinger, B.
- Affiliations
- National Institute for Medical Research (GB)
- Essen University Hospital (DE)
- Ludwig Cancer Research (BE)
- Corresponding author
- Stockinger, Brigitta
- ORCID
- Venue
- Nature
- Published
- 2008-03-23
- Volume
- 453
- Issue
- 7191
- Pages
- 106-109
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1993003564
- Cited by
- 1,634
- References
- 31
- Citations by year
- 2026: 33 · 2025: 44 · 2024: 49 · 2023: 54 · 2022: 87 · 2021: 94 · 2020: 96 · 2019: 90 · 2018: 96 · 2017: 93 · 2016: 96 · 2015: 82 · 2014: 114 · 2013: 107 · 2012: 118
- FWCI
- 52.43
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- HZI (Helmholtz Centre for Infection Research) (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DIAL (Catholic University of Leuven) (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- University of Leicester
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Immunotoxicology and immune responses
- Keywords
- aryl hydrocarbon receptor, Th17 cells, autoimmunity, environmental toxins, IL-22, experimental autoimmune encephalitis, multiple sclerosis, regulatory T cells, CD4+ T cells, immunomodulation, AhR ligands, dioxins, IL-17
- MeSH terms
- Interleukin-22, Animals, Cell Differentiation, Cells, Cultured, Encephalomyelitis, Autoimmune, Experimental, Environmental Exposure, Environmental Pollutants, T-Lymphocytes, Helper-Inducer, Humans, Interleukins, Ligands, Mice, Inbred C57BL, Transduction, Genetic, Hazardous Substances, Autoimmunity, Receptors, Aryl Hydrocarbon, Interleukin-17, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
